Extrawell Pharmaceutical Holdings Limited (HKG:0858)
Hong Kong · Delayed Price · Currency is HKD 0.0840
0.00 (0.00%)
Sep 18, 2026, 3:59 PM HKT
HKG:0858 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 244 | 204 | 108 | 72 | 160 | 208 | |
Market Cap Growth | -20.39% | 89.68% | 50.00% | -55.22% | -22.99% | -44.23% |
Enterprise Value | 220 | 263 | -633 | 86 | -551 | 157 |
Last Close Price | 0.08 | 0.08 | 0.04 | 0.03 | 0.07 | 0.09 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 0.48 | - | 1.24 | 1.59 |
Forward PE | - | 196.67 | 196.67 | 196.67 | 196.67 | 196.67 |
PS Ratio | 4.73 | 3.96 | 1.94 | 1.21 | 2.21 | 2.81 |
PB Ratio | 0.65 | 0.54 | 0.08 | 0.06 | 0.13 | 0.18 |
P/TBV Ratio | 0.65 | 0.55 | 0.08 | 0.07 | 0.13 | 0.18 |
P/OCF Ratio | 727.16 | 608.96 | - | - | 135.70 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.28 | 5.11 | - | 1.46 | - | 2.13 |
EV/EBITDA Ratio | - | - | - | 105.35 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.45 | 0.45 | 0.11 | 0.11 | 0.08 | 0.07 |
Debt / EBITDA Ratio | - | - | - | 46.74 | - | - |
Net Debt / Equity Ratio | -0.06 | -0.06 | -0.64 | 0.02 | 0.00 | -0.02 |
Net Debt / EBITDA Ratio | 6.51 | 6.51 | 345.72 | 31.99 | 0.36 | 4.56 |
Net Debt / FCF Ratio | 33.56 | 33.56 | 114.76 | -5.34 | 0.31 | 2.56 |
Asset Turnover | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.06 |
Inventory Turnover | 5.97 | 5.97 | 5.59 | 5.90 | 7.22 | 4.54 |
Quick Ratio | 5.31 | 5.31 | 21.36 | 2.60 | 2.58 | 2.48 |
Current Ratio | 6.04 | 6.04 | 21.91 | 3.45 | 3.13 | 3.03 |
Return on Equity (ROE) | -114.34% | -114.34% | 18.27% | -13.50% | 10.61% | 11.95% |
Return on Assets (ROA) | -0.59% | -0.59% | -0.40% | -0.30% | -0.51% | -0.65% |
Return on Invested Capital (ROIC) | -1.54% | -2.40% | -1.11% | -0.53% | -0.93% | -1.21% |
Return on Capital Employed (ROCE) | -1.80% | -1.80% | -0.60% | -0.50% | -0.80% | -1.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -402.18% | -480.25% | 207.01% | -227.27% | 80.73% | 62.80% |
FCF Yield | -0.29% | -0.35% | -6.92% | -6.82% | -3.40% | -5.48% |
Buyback Yield / Dilution | 12.71% | 24.65% | -37.66% | 27.36% | - | -37.66% |